A powerful new technology for gene therapy is now available. The technology uses an integrase enzyme from phage phiC31 that mediates chromosomal integration of therapeutic genes into a limited number of native sequences in mammalian genomes. This innovative technique is the only one that provides efficient site-specific, rather than random, chromosomal integration. The method also provides permanent, strong expression of the therapeutic gene. The integrase system has been validated in animal models in a number of tissues, species, and diseases. The focus of this proposal is to use the phiC31 integrase system to create a novel methodology for safe, simple, and permanent transfer of genes to the retina of larger mammals. We demonstrated an electroporation method that was effective for DNA delivery to rat retina and showed that integrase provided strong, long-term expression of a marker gene in the retinal pigment epithelium. Methods will now be established to achieve efficient gene delivery and site-specific integration into the retina of rabbits, as a model for later dog and human work. Innovative electroporation methods will be developed with collaborators from physics and ophthalmology to achieve surgical placement of electrodes to provide effective and precise delivery of therapeutic DNA to the RPE, with minimal tissue damage. The phiC31 integrase will be utilized to provide site-specific genomic integration and long-term expression of transferred genes in the retina. Delivery parameters will initially be optimized with in vitro model systems, while imaging of luciferase in the rabbit eye will be employed in long-term in vivo studies. To lay the groundwork for studies in the RPE65 dog to follow, site-specific integration into cultured dog cells will be demonstrated and genomic integration hotspots will be characterized. These experiments will move the phiC31 integrase ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Eye Institute (NEI)
Type
Small Research Grants (R03)
Project #
1R03EY016702-01
Application #
6956986
Study Section
Special Emphasis Panel (ZEY1-VSN (01))
Program Officer
Dudley, Peter A
Project Start
2005-09-15
Project End
2007-08-31
Budget Start
2005-09-15
Budget End
2006-08-31
Support Year
1
Fiscal Year
2005
Total Cost
$158,050
Indirect Cost
Name
Stanford University
Department
Genetics
Type
Schools of Medicine
DUNS #
009214214
City
Stanford
State
CA
Country
United States
Zip Code
94305
Keravala, Annahita; Calos, Michele P (2008) Site-specific chromosomal integration mediated by phiC31 integrase. Methods Mol Biol 435:165-73
Calos, Michele P (2006) The phiC31 integrase system for gene therapy. Curr Gene Ther 6:633-45
Chalberg, Thomas W; Vankov, Alexander; Molnar, Fanni E et al. (2006) Gene transfer to rabbit retina with electron avalanche transfection. Invest Ophthalmol Vis Sci 47:4083-90